Health and Healthcare Systems

One of the world's largest banks has issued an alarming warning about antibiotic resistance

Ten pills of the antibiotic "Amoxicillin 1000mg" are seen at a pharmacy in Hanau, Germany, May 31, 2018.  REUTERS/Kai Pfaffenbach - RC1B8E7C34A0

The US uses antibiotics in around 70% of its agricultural products. Image: REUTERS/Kai Pfaffenbach

Aria Bendix
Innovation Reporter, Business Insider

One of the world's largest banks has issued a dire warning about the future of food safety.

According to the global research team at HSBC, the use of antibiotics in meat production could have "devastating" consequences for humanity.

When farmers feed antibiotics to their animals, they create antibiotic-resistant bacteria, which can lead to antibiotic-resistant "superbugs" in humans. Over time, this could make it difficult to treat even common infections like strep throat.

The report's authors liken the impact of antibiotic resistance to climate change: The causation may not be immediately clear, but the evidence suggests a catastrophic future.

Scientific experts now predict that antibiotic resistance could lead to 10 million deaths annually by 2050, exceeding cancer as one of the most common forms of death worldwide.

Image: BBC
Have you read?

While some of this is related to the overprescribing of antibiotics by doctors, it also has to do with the antibiotics that are fed to key sources of produce, such as chickens, cows, and pigs. According to the report, more than half of global antibiotics are used in agriculture rather than medicine.

Although China accounts for 60% of the world's agricultural antibiotics, the US also uses antibiotics in around 70% of its agricultural products.

Most of these antibiotics are used in meat production, which has risen by 90% per capita globally since the 1960s. In June, an analysis of more than 47,000 US government lab tests found an increase in the number of pork chops and ground beef that were contaminated with antibiotic-resistant bacteria.

According to HSBC, this has had a marked impact on the way restaurants, meat producers, and food retailers do business. In 2015, the US meat processor Tyson Foods vowed to stop using human antibiotics in its US chicken operations. Two years later, McDonald's pledged to get rid of HPCIAs— antibiotics that are critically important to human medicine — in its broiler chickens by 2027.

But not all companies are on board. The report finds that many dairy and meat producers in Asia and the Americas have an economic incentive to continue their high usage of antibiotics. In many cases, antibiotics allow them to produce meat faster and ward off diseases — particularly in crowded or unsanitary living conditions.

These financial gains could soon become irrelevant, the authors warn, as antibiotic resistance poses an increasing threat to humanity.

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Stay up to date:

Global Health

Related topics:
Health and Healthcare SystemsIndustries in Depth
Share:
The Big Picture
Explore and monitor how Global Health is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

The key health achievements of COP29, and other top health stories

Shyam Bishen

November 20, 2024

How equitable access to medicines can drive sustainable returns for investors

About us

Engage with us

  • Sign in
  • Partner with us
  • Become a member
  • Sign up for our press releases
  • Subscribe to our newsletters
  • Contact us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2024 World Economic Forum